alloCART-19 cell therapy / Fudan University 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
alloCART-19 cell therapy / Fudan University
NCT04173988: Study of alloCART-19 Cell Therapy in Pediatric Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Active, not recruiting
1
6
RoW
alloCART-19, allogeneic CAR-T19, Cyclophosphamide, no other intervention names, Fludarabine
Children's Hospital of Fudan University
ALL, Childhood B-Cell
10/24
07/25

Download Options